LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 583

Search options

  1. Article ; Online: Application of the Sampson equation to estimate LDL-C in children: Comparison with LDL direct measurement and Friedewald equation in the BLIP study.

    Cicero, Arrigo F G / Fogacci, Federica / Patrono, Daniela / Mancini, Rita / Ramazzotti, Eric / Borghi, Claudio / D'Addato, Sergio

    Nutrition, metabolism, and cardiovascular diseases : NMCD

    2021  Volume 31, Issue 6, Page(s) 1911–1915

    Abstract: ... low-density lipoprotein cholesterol (LDL-C) plasma level. In this context, we aimed to compare the reliability of the Friedewald's ...

    Abstract Background and aims: In epidemiological trials and in clinical practices, it is relevant to have affordable and reliable methods to measure the main lipid cardiovascular risk factors, and in particular low-density lipoprotein cholesterol (LDL-C) plasma level. In this context, we aimed to compare the reliability of the Friedewald's (LDL-Cf) and Sampson's (LDL-Cs) equations with the LDL-value dosed by a validated dosage method (LDL-Cd) in a large cohort of children.
    Methods and results: We considered the lipid values of 145 infants, 278 preschoolers, 810 scholar children, and 1372 adolescents (Total N. 2605, 1291 males, 1314 females), with mean total cholesterol (TC) = 169.8 ± 39.7 mg/dL, HDL-Cholesterol = 50.8 ± 12.7 mg/dL, non HDL-Cholesterol = 118.9 ± 35.9 mg/dL, Triglycerides (TG) = 90.3 ± 77.9 mg/dL, LDL-Cd = 106.2 ± 29.9 mg/dL, LDL-Cf = 100.9 ± 33.8 mg/dL, and LDL-Cs = 102.2 ± 33.4 mg/dL. Comparing the distance to the LDL-Cd, Friedewald's equation mildly but significantly underestimated in infants (3.4 ± 5.3 mg/dL), preschoolers (1.5 ± 7.1 mg/dL). Children (1.2 ± 2.2 mg/dL) and adolescents (1.1 ± 5.9 mg/dL) compared to Sampson's equation (all comparisons, p < 0.001).
    Conclusions: Our analysis, being carried out on a large population sample, shows that Sampson's equation is more reliable than Friedewald's one at each considered age class and even for extreme TG values.
    MeSH term(s) Adolescent ; Age Factors ; Biomarkers/blood ; Child ; Child, Preschool ; Cholesterol, HDL/blood ; Cholesterol, LDL/blood ; Cross-Sectional Studies ; Female ; Humans ; Infant ; Italy ; Male ; Models, Biological ; Reproducibility of Results ; Triglycerides/blood
    Chemical Substances Biomarkers ; Cholesterol, HDL ; Cholesterol, LDL ; Triglycerides
    Language English
    Publishing date 2021-03-19
    Publishing country Netherlands
    Document type Comparative Study ; Journal Article
    ZDB-ID 1067704-5
    ISSN 1590-3729 ; 0939-4753
    ISSN (online) 1590-3729
    ISSN 0939-4753
    DOI 10.1016/j.numecd.2021.02.034
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Evaluation of twelve formulas for LDL-C estimation in a large, blinded, random Italian population.

    Piani, Federica / Cicero, Arrigo F G / Ventura, Fulvio / Dormi, Ada / Fogacci, Federica / Patrono, Daniela / Mancini, Rita / Ramazzotti, Eric / Borghi, Claudio / D'Addato, Sergio

    International journal of cardiology

    2021  Volume 330, Page(s) 221–227

    Abstract: Background and aims: Low-density lipoprotein-cholesterol (LDL-C) is the major determinant ... worldwide available, indirect formulas represent the most used laboratory estimation of LDL-C. In this study ... we analyzed the accuracy of twelve formulas for LDL-C estimation in an Italian population of 114,774 ...

    Abstract Background and aims: Low-density lipoprotein-cholesterol (LDL-C) is the major determinant of cardiovascular disease (CVD) burden. Being the direct assays time consuming, expensive, not fully standardized and not worldwide available, indirect formulas represent the most used laboratory estimation of LDL-C. In this study we analyzed the accuracy of twelve formulas for LDL-C estimation in an Italian population of 114,774 individuals.
    Methods: All lipid samples were analyzed using direct homogeneous assay. The population was divided into various subgroups based on triglycerides and directly dosed LDL-C (D-LDL) levels. Twelve formulas (Friedewald, DeLong, Hata, Hattori, Puavillai, Anandaraja, Ahmadi, Chen, Vujovic, de Cordova, Martin, and Sampson) were compared in terms of their mean absolute deviations and the correlation and concordance of their estimated LDL-C with the respective D-LDL values.
    Results: LCL-C measured by Friedewald formula and direct assay differed by more than 9 mg/dL. For D-LDL>115 mg/dl, we observed a concordance rate of only 55% between Friedewald and the respective D-LDL values. For TG<250 mg/dl, the proportion of reclassification between the different formulas and D-LDL was 14.1% with Vujovic, 14.4% Sampson, 15.9% DeLong, 16.5% Puavilai, 19.9% Martin, 21.9% Friedewald, 23.5% Chen, 29% Anandaraja, 31.1% Ahmadi, 31.5% Hata, 33.2% Hattori, and 44.4% with De Cordova formula.
    Conclusions: Our study compared for the first time 12 different LDL-C formulas on a Southern European population of more than 100,000 people. 'Several formulas showed better accuracy compared to Friedewald. Sampson, Martin and Vujovic resulted the most accurate formulas.
    MeSH term(s) Cholesterol, LDL ; Humans ; Italy/epidemiology ; Triglycerides
    Chemical Substances Cholesterol, LDL ; Triglycerides
    Language English
    Publishing date 2021-02-11
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 779519-1
    ISSN 1874-1754 ; 0167-5273
    ISSN (online) 1874-1754
    ISSN 0167-5273
    DOI 10.1016/j.ijcard.2021.02.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Cyclooxygenase Inhibitors and Cancer: The Missing Pieces.

    Patrono, Carlo

    The Journal of pharmacology and experimental therapeutics

    2023  Volume 386, Issue 2, Page(s) 181–189

    Abstract: At 125, aspirin still represents the cornerstone of anti-platelet therapy for the acute treatment and long-term prevention of atherothrombosis. The development of a selective regimen of low-dose aspirin for the inhibition of platelet thromboxane ... ...

    Abstract At 125, aspirin still represents the cornerstone of anti-platelet therapy for the acute treatment and long-term prevention of atherothrombosis. The development of a selective regimen of low-dose aspirin for the inhibition of platelet thromboxane production was key to maximizing its antithrombotic efficacy and minimizing its gastrointestinal toxicity. Based on about 50 observational studies, published over the past 30 years, aspirin and other cyclooxygenase inhibitors have been associated with a reduced risk of colorectal cancer, and possibly other digestive tract cancers. The apparent chemopreventive effect of aspirin has been confirmed in post-hoc analyses of randomized cardiovascular trials and their meta-analyses. Moreover, prevention of sporadic colorectal adenoma recurrence was demonstrated by randomized controlled trials of low-dose aspirin and selective cyclooxygenase-2 inhibitors. A single placebo-controlled randomized trial of aspirin has shown long-term colorectal cancer prevention in patients with the Lynch syndrome. The sequential involvement of thromboxane-dependent platelet activation and cyclooxygenase-2-driven inflammatory response in the early stages of colorectal carcinogenesis may explain these clinical benefits. The aim of this mini-review is to analyze the existing evidence for a chemopreventive effect of aspirin and other cyclooxygenase inhibitors and discuss the missing pieces of this mechanistic and clinical puzzle. SIGNIFICANCE STATEMENT: Low-dose aspirin and other cyclooxygenase inhibitors have been associated with a reduced risk of colorectal cancer, and possibly other digestive tract cancers. The sequential involvement of thromboxane-dependent platelet activation and cyclooxygenase-2-driven inflammatory response in the early stages of colorectal carcinogenesis may explain these clinical benefits. The aim of this mini-review is to analyze the evidence for a chemopreventive effect of aspirin and other cyclooxygenase inhibitors and discuss the missing pieces of this mechanistic and clinical puzzle.
    MeSH term(s) Humans ; Cyclooxygenase 2 ; Aspirin/pharmacology ; Aspirin/therapeutic use ; Cyclooxygenase 2 Inhibitors/pharmacology ; Cyclooxygenase 2 Inhibitors/therapeutic use ; Colorectal Neoplasms/drug therapy ; Colorectal Neoplasms/prevention & control ; Gastrointestinal Neoplasms/drug therapy ; Thromboxanes ; Carcinogenesis ; Cyclooxygenase 1 ; Platelet Aggregation Inhibitors ; Randomized Controlled Trials as Topic
    Chemical Substances Cyclooxygenase 2 (EC 1.14.99.1) ; Aspirin (R16CO5Y76E) ; Cyclooxygenase 2 Inhibitors ; Thromboxanes ; Cyclooxygenase 1 (EC 1.14.99.1) ; Platelet Aggregation Inhibitors
    Language English
    Publishing date 2023-06-06
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 3106-9
    ISSN 1521-0103 ; 0022-3565
    ISSN (online) 1521-0103
    ISSN 0022-3565
    DOI 10.1124/jpet.122.001631
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Aspirin: 1A @ 125.

    Patrono, Carlo

    European heart journal

    2022  Volume 43, Issue 34, Page(s) 3194–3195

    MeSH term(s) Humans ; Aspirin/therapeutic use ; Fibrinolytic Agents/therapeutic use ; Ticlopidine
    Chemical Substances Aspirin (R16CO5Y76E) ; Fibrinolytic Agents ; Ticlopidine (OM90ZUW7M1)
    Language English
    Publishing date 2022-08-08
    Publishing country England
    Document type Journal Article
    ZDB-ID 603098-1
    ISSN 1522-9645 ; 0195-668X
    ISSN (online) 1522-9645
    ISSN 0195-668X
    DOI 10.1093/eurheartj/ehac416
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Fifty years with aspirin and platelets.

    Patrono, Carlo

    British journal of pharmacology

    2022  Volume 180, Issue 1, Page(s) 25–43

    Abstract: In 2021, we reached the 50th anniversary of the publication of Sir John Vane's seminal paper in Nature New Biology describing the experiments supporting his mechanistic hypothesis that inhibition of prostaglandin synthesis might explain the main ... ...

    Abstract In 2021, we reached the 50th anniversary of the publication of Sir John Vane's seminal paper in Nature New Biology describing the experiments supporting his mechanistic hypothesis that inhibition of prostaglandin synthesis might explain the main pharmacological effects of aspirin and aspirin-like drugs, that is, reduction in pain, fever and inflammation. Bengt Samuelsson's subsequent discoveries elucidating the cyclooxygenase pathway of platelet arachidonic acid metabolism motivated my research interest towards measuring platelet thromboxane A
    MeSH term(s) Aspirin/pharmacology ; Cyclooxygenase Inhibitors/pharmacology ; Blood Platelets ; Platelet Aggregation Inhibitors/pharmacology ; Cyclooxygenase 2/metabolism
    Chemical Substances Aspirin (R16CO5Y76E) ; Cyclooxygenase Inhibitors ; Platelet Aggregation Inhibitors ; Cyclooxygenase 2 (EC 1.14.99.1)
    Language English
    Publishing date 2022-11-03
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 80081-8
    ISSN 1476-5381 ; 0007-1188
    ISSN (online) 1476-5381
    ISSN 0007-1188
    DOI 10.1111/bph.15966
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Weekly journal scan: it takes two for acute stroke.

    Liuzzo, Giovanna / Patrono, Carlo

    European heart journal

    2024  

    Language English
    Publishing date 2024-04-03
    Publishing country England
    Document type Journal Article
    ZDB-ID 603098-1
    ISSN 1522-9645 ; 0195-668X
    ISSN (online) 1522-9645
    ISSN 0195-668X
    DOI 10.1093/eurheartj/ehae166
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Balancing the benefits and risks of anticoagulation in patients with subclinical atrial fibrillation.

    Liuzzo, Giovanna / Patrono, Carlo

    European heart journal

    2024  Volume 45, Issue 10, Page(s) 754–755

    MeSH term(s) Humans ; Atrial Fibrillation/complications ; Atrial Fibrillation/drug therapy ; Anticoagulants/adverse effects ; Stroke/prevention & control ; Stroke/chemically induced ; Blood Coagulation ; Risk Assessment ; Risk Factors
    Chemical Substances Anticoagulants
    Language English
    Publishing date 2024-01-08
    Publishing country England
    Document type Journal Article
    ZDB-ID 603098-1
    ISSN 1522-9645 ; 0195-668X
    ISSN (online) 1522-9645
    ISSN 0195-668X
    DOI 10.1093/eurheartj/ehad859
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Weekly journal scan: SURMOUNTing body weight regain with tirzepatide after successful lifestyle intervention.

    Liuzzo, Giovanna / Patrono, Carlo

    European heart journal

    2024  Volume 45, Issue 16, Page(s) 1392–1394

    MeSH term(s) Humans ; Body Weight ; Obesity ; Weight Gain ; Life Style ; Diabetes Mellitus, Type 2 ; Hypoglycemic Agents ; Glucagon-Like Peptide-2 Receptor ; Gastric Inhibitory Polypeptide
    Chemical Substances tirzepatide (OYN3CCI6QE) ; Hypoglycemic Agents ; Glucagon-Like Peptide-2 Receptor ; Gastric Inhibitory Polypeptide (59392-49-3)
    Language English
    Publishing date 2024-01-27
    Publishing country England
    Document type Journal Article
    ZDB-ID 603098-1
    ISSN 1522-9645 ; 0195-668X
    ISSN (online) 1522-9645
    ISSN 0195-668X
    DOI 10.1093/eurheartj/ehae076
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: The EHJ Weekly Journal Scan: Why? Who? How?

    Patrono, Carlo

    European heart journal

    2020  Volume 42, Issue 3, Page(s) 224–226

    Language English
    Publishing date 2020-12-12
    Publishing country England
    Document type Journal Article
    ZDB-ID 603098-1
    ISSN 1522-9645 ; 0195-668X
    ISSN (online) 1522-9645
    ISSN 0195-668X
    DOI 10.1093/eurheartj/ehaa978
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Reducing cardiovascular outcomes with semaglutide: a metabolic route for a SELECT few.

    Liuzzo, Giovanna / Patrono, Carlo

    European heart journal

    2023  Volume 45, Issue 8, Page(s) 570–571

    MeSH term(s) Humans ; Glucagon-Like Peptides/therapeutic use ; Cardiovascular System ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/drug therapy ; Hypoglycemic Agents/therapeutic use
    Chemical Substances semaglutide (53AXN4NNHX) ; Glucagon-Like Peptides (62340-29-8) ; Hypoglycemic Agents
    Language English
    Publishing date 2023-12-15
    Publishing country England
    Document type Journal Article
    ZDB-ID 603098-1
    ISSN 1522-9645 ; 0195-668X
    ISSN (online) 1522-9645
    ISSN 0195-668X
    DOI 10.1093/eurheartj/ehad823
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top